FINWIRES · TerminalLIVE
FINWIRES

$IMUX

2 stories mentioning IMUXUpdated 37d ago

Every FINWIRES story that references IMUX, newest first.

What are analysts saying about IMUX?

Recent broker actions mentioned in FINWIRES coverage. Compiled from wire headlines; not investment advice.

What's the latest news on IMUX?

Research

Wedbush Initiates Immunic at Outperform With $45 Price Target

Immunic (IMUX) has an average rating of buy and mean price target of $41.90, according to analysts polled by FactSet.

$IMUX
Research

Stifel Nicolaus Initiates Coverage on Immunic With Buy Rating, $2.50 Price Target

Immunic (IMUX) has an average rating of Buy and mean price target of $4.94, according to analysts polled by FactSet.

$IMUX

Track with the FINWIRES app suite

FolioX
FolioX
Track IMUX in your portfolio
WheelAI
WheelAI
Analyze IMUX options with the wheel strategy
StockInsider
StockInsider
See market sentiment on IMUX